rs370436662
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BP6
The NM_001277115.2(DNAH11):āc.3494A>Gā(p.Asp1165Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000142 in 1,613,744 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000165 AC: 41AN: 248978Hom.: 1 AF XY: 0.000141 AC XY: 19AN XY: 135066
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461520Hom.: 1 Cov.: 31 AF XY: 0.000127 AC XY: 92AN XY: 727024
GnomAD4 genome AF: 0.000112 AC: 17AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74362
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:1
The c.3494A>G (p.D1165G) alteration is located in exon 18 (coding exon 18) of the DNAH11 gene. This alteration results from a A to G substitution at nucleotide position 3494, causing the aspartic acid (D) at amino acid position 1165 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
- -
not specified Uncertain:1
The p.Asp1165Gly variant in DNAH11 has not been previously reported in individuals with primary ciliary dyskinesia but has been identified in 0.03% (43/128306) of European chromosomes by gnomAD, including one homozygous individual (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 454670). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: None. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at